Skip to content
    A hand with a pencil over a printed dashboard, a laptop beside it
    Blogs

    Hospital Pricing: Payer Mix, Package Rates and the Money You Never Collect

    September 18, 2026 · Article · 8 min read

    Sriram ChidambaramFounder & Managing Partner

    You billed ₹2.4 lakh. The insurer approved ₹1.9 lakh. You collected ₹1.7 lakh, ninety days later.

    Summary

    • A hospital's tariff is a starting position. What it earns depends on four or five payers with completely different economics for the same procedure, bed and surgeon.
    • Margin disappears in four places: package rates set once and never revisited, disallowances nobody analyses, payer mix drifting quietly, and long collection cycles.
    • The number to manage is realised revenue per payer per procedure, against the direct cost of delivering it. Very few hospitals have it.

    Ask a hospital promoter what a procedure costs and you'll be shown the tariff.

    The tariff is a starting position. It's what you'd charge a patient paying from their own pocket, and depending on the hospital, that patient may be a small minority of the people walking through the door.

    What you actually earn depends on who is paying. And in most Indian hospitals, the answer is four or five different payers with four or five completely different economics: self-pay, corporate, private insurance through a third-party administrator, government scheme, and institutional or panel arrangements.

    Same procedure. Same bed. Same surgeon. Very different money.

    That's what makes hospital pricing unlike almost any other business: your price is largely decided by your payer mix, and your payer mix is something most hospitals track as a statistic rather than manage as a lever.

    Walk the money down

    Take a procedure with a tariff of ₹2,40,000.

    One procedure, from tariff billed to cash kept

    StepRunning ₹
    Tariff billed2,40,000
    Package cap: the agreed rate is below tariff(30,000)2,10,000
    Items disallowed on review: consumables, non-payables(20,000)1,90,000
    Approved amount1,90,000
    Deductions at settlement(12,000)1,78,000
    Cost of waiting 90 days to be paid(6,500)1,71,500
    Write-off on the portion never recovered(4,000)1,67,500
    What you actually keep1,67,500
    Source: Illustrative figures, as set out in this article

    Tariff ₹2.4 lakh. Realised ₹1.67 lakh. Thirty percent gone, and very little of it visible in a revenue report that stops at billing. It is the pocket price waterfall, in a hospital's own terms.

    These are illustrative numbers. Your package rates, disallowance patterns and collection cycles will differ. The method is the point.

    The four places margin disappears

    Package rates that were set once. A rate agreed with an insurer or a scheme three years ago, when your cost base was different. Consumable costs have risen, implant prices have moved, salaries have gone up, and the rate hasn't. Most hospitals renegotiate reactively, when a rate becomes obviously unworkable, rather than on a schedule.

    Disallowances nobody analyses. Items billed and then rejected on review: consumables not covered, documentation gaps, coding that didn't match. These get written off individually as an administrative annoyance. Added up across a year they are substantial, and the pattern is learnable. Most disallowances repeat.

    Payer mix drifting quietly. A shift of a few percentage points from self-pay or corporate toward lower-paying government schemes changes your realised revenue per bed without any single decision being made. It shows up in the bank before it shows up in any report, because your occupancy and your bill volumes look unchanged.

    Long collection cycles. Ninety days is common, and considerably longer is not unusual with some payers. At a 14% cost of money, ninety days costs you around 3.5% of the approved amount: a permanent discount nobody negotiated.

    The number to manage: realised revenue per payer

    Not tariff. Not billed revenue. What you actually collect, by payer, by procedure.

    Build it once and it changes several conversations at the same time.

    You'll find procedures that are comfortably profitable under one payer and loss-making under another. You'll find package rates that no longer cover the consumables the package requires. And you'll find that your best specialty on a tariff basis is not your best specialty on a realised basis.

    That single table, realised revenue per payer per procedure against the direct cost of delivering it, is the foundation of hospital pricing. Very few hospitals we work with have it.

    Payer mix is a decision, not a fact

    This is the part worth pushing on, because most hospitals treat their mix as something that happens to them.

    It isn't entirely. You influence it through which empanelments you pursue and which you let lapse, how you market to self-pay patients, which corporate tie-ups you invest in, which specialties you grow, and which referral relationships you build.

    None of that is fast, and none of it is free. But over two or three years, mix is steerable, and a two-point shift in mix is often worth more than a tariff revision, without the public sensitivity a tariff revision carries.

    Three things to know before you can steer it:

    • Contribution margin by payer, by specialty. Which combinations pay you properly and which don't.
    • Capacity implications. A lower-paying payer that fills beds you'd otherwise leave empty is not the same as one displacing a better-paying patient. Empty capacity earns nothing.
    • Obligations. Some empanelments carry commitments, and some carry reputational or community considerations that aren't purely commercial. Those are legitimate reasons to keep a payer that doesn't pay well. They should just be conscious choices rather than accidents.

    Charge capture: money you already earned

    Separate from pricing but closely connected, because it hits the same line.

    Hospitals lose revenue they have already delivered. Consumables used in theatre but not recorded. Procedures under-coded. Services provided and never entered. A discount applied at the counter with no approval trail.

    This is not a pricing problem. The price was right, the work was done, and the bill was wrong. But it lands in the same place, and in most hospitals it is worth more than any tariff increase would be. It is a capture problem, not a close problem.

    A hospital that tightens charge capture and cuts its disallowance rate often finds more money inside its existing patient volume than a marketing campaign would bring in, because that revenue was already earned and simply lost on the way to the bank.

    Diagnostics is a different business

    Worth treating separately, because the economics don't resemble the hospital core.

    Diagnostics is high volume, lower ticket, and split between two very different customers.

    Walk-in patients pay near the list rate and are won on convenience, location and turnaround.

    Referrals from doctors and other labs are B2B, negotiated, and this is where realisation slides. Discounting to win referral volume is normal, it compounds quietly, and in many chains the B2B rate has drifted far below what anyone intended.

    Four things decide diagnostics economics: test volume, realisation per test, turnaround time, and the of home collection, which is often priced as a convenience and costs considerably more than the fee charged for it.

    The discipline is the same as everywhere else. Know your realised rate per test per channel, and know the cost of the test including the share of fixed equipment and staffing it carries. A chain that treats every test as the same rupee will slowly be filled with the ones that aren't worth doing.

    Package design is pricing

    One structural point that gets treated as a clinical matter.

    What goes inside a package determines whether the package makes money. If your package includes a consumable whose cost has risen 30% since the rate was agreed, you're absorbing that on every case.

    So package composition needs a periodic commercial review alongside the clinical one: which items are included, what they now cost, what the exclusions are, and whether the rate still works. Annually at minimum, and immediately when an input cost moves materially.

    This also affects how a package gets used. A well-designed package with clear inclusions and documented exclusions produces fewer disallowances, because the payer's review has less to argue with.

    Where to start

    Pick your three highest-volume procedures. For each, build the full waterfall from tariff to cash collected, separately for every payer.

    Then put your direct cost of delivering that procedure next to each column. It depends on clean numbers underneath, which in a hospital is its own piece of work.

    Most hospital promoters have never seen this, and the first look typically explains something that had been puzzling for years: why the occupancy is good, the bills are large, and the bank balance is disappointing.

    Our Pricing Maturity Assessment covers this alongside cost structure and the rest of your pricing.

    Frequently asked questions

    What is payer mix and why does it matter for hospital pricing?

    Payer mix is the split of your revenue across self-pay patients, corporates, insurers, government schemes and institutional arrangements. It matters because each pays a different amount for the same procedure, so your realised revenue per bed can change significantly without your tariff, occupancy or case volume changing at all.

    How do I reduce insurance disallowances?

    Analyse them rather than writing them off case by case. Most disallowances repeat: the same items, the same documentation gaps, the same coding issues. Fix the pattern at source through clearer package inclusions, better documentation at the point of care, and coding review before submission.

    How should a diagnostics chain price B2B referrals?

    Start from your realised rate per test per channel and your fully loaded cost per test, including the share of equipment and staffing it carries. B2B referral rates erode quietly because each discount is negotiated separately, so set a floor, govern who can go below it, and review realised rates by referring partner rather than in aggregate.

    How useful was this article?

    One tap. It tells us what to write more of.

    Not usefulVery useful

    About the author

    Sriram Chidambaram

    Founder & Managing Partner

    Everything Sriram has writtenLinkedIn

    The next one

    Get what we publish next, by email.

    Working notes on raising, borrowing, protecting, growing and structuring capital in India. One email a week at most, and you can leave any time.

    We use your address only to send this. See our privacy policy.

    We store your address to send you these emails and nothing else. See our privacy policy.

    Related reading